August 5, 2024
This joint effort will harness PacBio's state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore’s multi-ethnic population SINGAPORE -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore (PRECISE) has chosen the Revio HiFi sequencing system for [...]
Molecular Devices Launches AI-Powered QPix Insights App for Microbial Colony Picking
August 5, 2024
New software enhances data analysis and visualization in automated microbial colony picking SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched QPix® Insights, a cutting-edge software solution designed to streamline and enhance the microbial colony analysis process on the company’s QPix® Microbial Colony Pickers. Developed collaboratively by Molecular Devices [...]
Illumina launches new oncology menu for NovaSeq X Series customers
August 5, 2024
Delivers Illumina's flagship oncology products on its most powerful sequencers to enable comprehensive genomic profiling at greater scale and at lower overall costs for customers SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series customers. The [...]
August 5, 2024
SOUTH SAN FRANCISCO, Calif. & TOKYO--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and bitBiome Inc., a biotechnology company unlocking the potential of our planet’s microbes to power the future of the bioeconomy, today announced the launch of a joint Transaminase [...]
August 3, 2024
Singapore’s National Precision Medicine (NPM) programme will sequence 10,000 genomes to improve understanding of genetic architecture and diversity in Singapore’s multi-ethnic Asia population through advanced, nanopore-based sequencing technology Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme , led by Precision Health Research, Singapore (PRECISE), aimed at [...]
August 2, 2024
Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Enamine, the world’s leading chemical and biological contract research organization and producer of novel building blocks for drug design, in the area of targeted protein degradation (TPD). TPD is an exciting research [...]
Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
August 1, 2024
Merck today announced the closing of the transaction to acquire Mirus Bio for approximately US$ 600 million. Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement Merck’s upstream bioprocessing portfolio Combined portfolio meets customer needs as demand for novel modalities grows Darmstadt, Germany [...]
Picarro Signs Master Agreement with Italgas, Extending Through 2031
August 1, 2024
Santa Clara, CA – Picarro Inc., a global leader in methane emission measurement, quantification, and reduction solutions, today announced the signing of a milestone Master Agreement with Italgas. Effective from 2024 through 2031, this strategic partnership demonstrates Italgas’ continued trust in Picarro’s technology and its commitment to sustainability, safety, and digitizing the gas network. The Master [...]
August 1, 2024
Phenomenex broadens its "Designed for PFAS" Portfolio with the expansion of the Strata PFAS Solid Phase Extraction (SPE) offerings for Enhanced PFAS Sample Preparation Single and dual formats quickly remove matrix interferences, ensuring better recoveries and detection limits with fewer errors, less solvent use, and cost savings TORRANCE, Calif. -- Phenomenex Inc., a global leader in [...]
Hitachi High-Tech Acquires Majority Interest in Nabsys
August 1, 2024
Tokyo and Providence, RI – Hitachi High-Tech Corporation (Hitachi High-Tech) and Nabsys 2.0 LLC (Nabsys) announced today that Hitachi High-Tech has acquired a majority interest in Nabsys, a developer and manufacturer of instrumentation and consumables for the analysis of genomic structural variation. This transaction will make Nabsys a consolidated subsidiary of Hitachi High-Tech Group. Hitachi [...]

